Accelerated Bachmann Bundle Pacing Study for Heart Failure
ClinicalTrials.gov Studies
Summary
ClinicalTrials.gov has registered study NCT07547306, a clinical investigation evaluating the effect of accelerated atrial resynchronization through Bachmann bundle pacing at the time of implantable cardioverter-defibrillator implantation. The trial enrolls patients with heart failure with reduced ejection fraction and interatrial block. Three intervention arms are studied: BBAP on, BBAP off, and RAAP (right atrial appendage pacing).
“To evaluate the effect of accelerated atrial resynchronization achieved through Bachmann bundle pacing at the time of implantable cardioverter-defibrillator implantation in patients with heart failure with reduced ejection fraction and interatrial block”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This entry adds a new clinical trial registry record for NCT07547306, an interventional study conducted under NIH registration on ClinicalTrials.gov. The trial evaluates Bachmann bundle atrial pacing (BBAP) in patients with heart failure with reduced ejection fraction and interatrial block who are indicated for implantable cardioverter-defibrillator placement.
Affected parties include clinical investigators conducting cardiac device research, hospitals performing ICD implantations, and patients meeting the enrollment criteria of heart failure with reduced ejection fraction and interatrial block. The registry entry provides study objectives and design but does not impose compliance obligations beyond standard clinical trial conduct requirements.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Evaluation of Accelerated Bachmann Bundle Area Pacing in Heart Failure With Reduced ejectIon Fraction Who Have electrocarDioGraphic Evidence of Interatrial Block and Indicated for Implantable Cardioverter Defibrillator
N/A NCT07547306 Kind: NA Apr 23, 2026
Abstract
To evaluate the effect of accelerated atrial resynchronization achieved through Bachmann bundle pacing at the time of implantable cardioverter-defibrillator implantation in patients with heart failure with reduced ejection fraction and interatrial block
Conditions: Heart Failure and Reduced Ejection Fraction
Interventions: BBAP on, BBAP off, RAAP
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.